npj Precision Oncology (Jan 2024)

Exploiting tumor aneuploidy as a biomarker and therapeutic target in patients treated with immune checkpoint blockade

  • Liam F. Spurr,
  • Sean P. Pitroda

DOI
https://doi.org/10.1038/s41698-023-00492-8
Journal volume & issue
Vol. 8, no. 1
pp. 1 – 3

Abstract

Read online

No abstracts available.